UBS Group’s Accelerate Diagnostics AXDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $14 | Sell |
|
|||||
|
2024
Q4 | $48 | Hold |
|
|||||
|
2024
Q3 | $68 | Hold |
|
|||||
|
2024
Q2 | $47 | Sell |
|
|||||
|
2024
Q1 | $4.99K | Sell |
|
|||||
|
2023
Q4 | $39.1K | Buy |
|
|||||
|
2023
Q3 | $29.2K | Sell |
|
|||||
|
2023
Q2 | $41.2K | Buy |
|
|||||
|
2023
Q1 | $35.6K | Buy |
|
|||||
|
2022
Q4 | $568 | Sell |
|
|||||
|
2022
Q3 | $13K | Sell |
|
|||||
|
2022
Q2 | $44K | Buy |
|
|||||
|
2022
Q1 | $6K | Sell |
|
|||||
|
2021
Q4 | $74K | Buy |
|
|||||
|
2021
Q3 | $14K | Sell |
|
|||||
|
2021
Q2 | $51K | Sell |
|
|||||
|
2021
Q1 | $148K | Buy |
|
|||||
|
2020
Q4 | $133K | Buy |
|
|||||
|
2020
Q3 | $94K | Sell |
|
|||||
|
2020
Q2 | $1.29M | Sell |
|
|||||
|
2020
Q1 | $1.68M | Sell |
|
|||||
|
2019
Q4 | $3.5M | Buy |
|
|||||
|
2019
Q3 | $3.01M | Sell |
|
|||||
|
2019
Q2 | $4.03M | Buy |
|
|||||
|
2019
Q1 | $3.6M | Sell |
|
|||||
|
2018
Q4 | $2.35M | Buy |
|
|||||
|
2018
Q3 | $4.49M | Buy |
|
|||||
|
2018
Q2 | $4.13M | Buy |
|
|||||
|
2018
Q1 | $3.9M | Sell |
|
|||||
|
2017
Q4 | $4.95M | Buy |
|
|||||
|
2017
Q3 | $4M | Buy |
|
|||||
|
2017
Q2 | $4.52M | Buy |
|
|||||
|
2017
Q1 | $3.51M | Buy |
|
|||||
|
2016
Q4 | $2.82M | Sell |
|
|||||
|
2016
Q3 | $3.8M | Buy |
|
|||||
|
2016
Q2 | $1.85M | Buy |
|
|||||
|
2016
Q1 | $1.81M | Sell |
|
|||||
|
2015
Q4 | $2.74M | Buy |
|
|||||
|
2015
Q3 | $1.37M | Buy |
|
|||||
|
2015
Q2 | $2.15M | Sell |
|
|||||
|
2015
Q1 | $2.04M | Sell |
|
|||||
|
2014
Q4 | $1.8M | Buy |
|